Purified anti-human CD28 Antibody

Pricing & Availability
Clone
CD28.2 (See other available formats)
Regulatory Status
RUO
Workshop
V-CD28.05
Other Names
T44, Tp44
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
28.2
Human peripheral blood lymphocytes stained with CD28.2 PE
  • 28.2
    Human peripheral blood lymphocytes stained with CD28.2 PE
Compare all formats
Cat # Size Price Quantity Check Availability Save
302901 25 µg 20€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
302902 100 µg 40€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD28 is a 44 kD disulfide-linked homodimeric type I glycoprotein. It is a member of the immunoglobulin superfamily and is also known as T44 or Tp44. CD28 is expressed on most T lineage cells, NK cell subsets, and plasma cells. CD28 binds both CD80 and CD86 using a highly conserved motif MYPPY in the CDR3-like loop. CD28 is considered a major co-stimulatory molecule, inducing T lymphocyte activation and IL-2 synthesis, and preventing cell death. In vitro studies indicate that ligation of CD28 on T cells by CD80 and CD86 on antigen presenting cells provides a costimulatory signal required for T cell activation and proliferation.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human, Cynomolgus, Rhesus
Reported Reactivity
Baboon, Capuchin Monkey, Chimpanzee, Pigtailed Macaque, Sooty Mangabey, Squirrel Monkey
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F, Costim, FA - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.5 µg per 106 cells in 100 µl volume or 100 µl whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

The Ultra-LEAF™ Purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for highly sensitive assays.

Application References
  1. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
  2. Nunes J, et al. 1993. Biochem. J. 293:835.
  3. Calea-Lauri J, et al. 1999. J. Immunol. 163:62.
  4. Tazi A, et al. 1999. J. Immunol. 163:3511. (IHC)
  5. Marti F, et al. 2001. J. Immunol. 166:197. (Costim)
  6. Jeong SH, et al. 2004. J. Virol. 78:6995. (Costim)
  7. Rivollier A, et al. 2004. Blood 104:4029. (Costim)
  8. Scharschmidt E, et al. 2004. Mol. Cell Biol. 24:3860. (Costim)
  9. Sheng W, et al. 2007.Elsevier 580:6819. PubMed
  10. Mitsuhashi M. 2007. Clin Chem.53:148. PubMed
  11. Ye Z, et al. 2008. Infect. Immun. 76:2541. PubMed
  12. Magatti M, et al. 2008. Stem Cells 26:182. (FA) PubMed
  13. Yoshino N, et al. 2008. Exp. Anim. (Tokyo) 49:97. (FC)
  14. Berg M, et al. 2008. J Leukoc Biol. 83:853. (IP) PubMed
  15. Rout N, et al. 2010. PLoS One 5:e9787. (FC)
  16. Leonard JA, et al. 2011. J. Virol. 85:6867. PubMed
  17. Nomura T, et al. 2012. J. Virol. 86:6481. PubMed
Product Citations
  1. Mammadli M, et al. 2021. Clin Transl Med. 11:e625. PubMed
  2. Mousset CM, et al. 2018. Oncoimmunology. 7:e1488565. PubMed
  3. Mitsuhashi M 2007. Clin Chem. 53:148. PubMed
  4. Liu L, et al. 2016. Nat Biotechnol. 10.1038/nbt.3461. PubMed
  5. Panigrahi S, et al. 2020. PLoS Pathog. e1008885:16. PubMed
  6. Li G, et al. 2021. Oncoimmunology. 10:1983306. PubMed
  7. Zhang Y, et al. 2019. Cell Res. 29:609. PubMed
  8. Friebel E, et al. 2020. Cell. 181(7):1626-1642.e20. PubMed
  9. Zhu Y, et al. 2019. Front Genet. 10:141. PubMed
  10. Ahmed R et al. 2019. Cell. 177(6):1583-1599 . PubMed
  11. Liang J, et al. 2017. Nat Commun. 8:15732. PubMed
  12. Zucchetti AE, et al. 2019. Nat Commun. 10:2864. PubMed
  13. Barzilai S, et al. 2017. Cell Rep. 18(3):685-699. PubMed
  14. Taft J, et al. 2021. Cell. 184(17):4447-4463.e20. PubMed
  15. Xiao C, et al. 2022. iScience. 25:103934. PubMed
  16. Tocheva AS, et al. 2020. J Biol Chem. 295:18036. PubMed
  17. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  18. Bluhm J, et al. 2018. Mol Ther. 26:1906. PubMed
  19. Fasbender F, et al. 2017. Front Immunol. 0.88125. PubMed
  20. Willimsky G, et al. 2021. Elife. 10:. PubMed
  21. Song C, et al. 2022. Stem Cell Res Ther. 13:48. PubMed
  22. Peng Q, et al. 2022. EBioMedicine. 77:103904. PubMed
  23. Bobardt M, et al. 2020. PLoS One. 15:e0227715. PubMed
  24. Haas R, et al. 2015. PLoS Biol. 13: 1002202. PubMed
  25. Ye Z, et al. 2008. Infect Immun. 76:2541. PubMed
  26. Woolsey C, et al. 2020. Scientific Reports. 10(1):3071.. PubMed
  27. Holbrook AK, et al. 2019. Physiol Rep. 7:e14234. PubMed
  28. Nathan A, et al. 2021. Cell. 184(17):4401-4413.e10. PubMed
  29. Kaufmann M, et al. 2021. Med. 2(3):296-312.e8. PubMed
  30. Gaa R, et al. 2021. MAbs. 13:1978130. PubMed
  31. Wilson AS, et al. 2022. Nat Commun. 13:528. PubMed
  32. Kondo H, et al. 2022. Front Immunol. 13:836923. PubMed
  33. Dias J, et al. 2018. Proc Natl Acad Sci U S A. 115:E11513. PubMed
  34. Oberg HH, et al. 2020. J Leukoc Biol. 107:1081. PubMed
  35. Li L, et al. 2020. J Transl Med. 18:363. PubMed
  36. Meléndez AV, et al. 2022. Cell Mol Life Sci. 79:513. PubMed
  37. Le X, et al. 2021. J Thorac Oncol. 16:583. PubMed
  38. Qiu C, et al. 2022. Front Immunol. 12:764949. PubMed
  39. Hu X, et al. 2021. British Journal of Pharmacology. 178(6):1445-1458. PubMed
  40. Li H, et al. 2020. Front Immunol. 11:1777. PubMed
  41. O'Boyle KC, et al. 2020. Methods Mol Biol. 2111:1. PubMed
  42. Guo T, et al. 2018. J Immunol. 200:500. PubMed
  43. Jin H, et al. 2019. MBio. 10:e01769-19. PubMed
  44. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  45. Cai J, et al. 2021. eLife. 10:00. PubMed
  46. Liu Y, et al. 2022. Micromachines (Basel). 13:. PubMed
  47. Zhu Y, et al. 2019. Cell Stem Cell. 25:542. PubMed
  48. Kinosada H, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006120. PubMed
  49. Jakob M, et al. 2020. Cells. 10:. PubMed
  50. Tocheva AS, et al. 2020. J Biol Chem. 295:18036. PubMed
  51. Sattler A, et al. 2021. Am J Transplant. 21:87. PubMed
  52. Leonard J, et al. 2011. J Virol. 85:6867. PubMed
  53. Seo N, et al. 2018. Nat Commun. 9:435. PubMed
  54. Qiu H, et al. 2017. Exp Cell Res.. 10.1016/j.yexcr.2017.08.036. PubMed
  55. Wiedeman AE, et al. 2020. J Clin Invest. 130:480. PubMed
  56. Jin Y, et al. 2017. Int Immunopharmacol. . 10.1016/j.intimp.2017.10.009. PubMed
  57. Pardons M, et al. 2019. PLoS Pathog. 15:e1007619. PubMed
  58. Gee MH, et al. 2018. Cell. 172:549. PubMed
  59. Bonavia AS, et al. 2022. Front Immunol. 13:940030. PubMed
  60. Levin SD, et al. 2020. Front Immunol. 10:3086. PubMed
  61. Singh AK, et al. 2017. Front Immunol. 0.513888889. PubMed
  62. Zavidij O, et al. 2020. Nat Cancer. 0.384027778. PubMed
  63. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  64. Duque JSR, et al. 2022. Nat Commun. 13:3700. PubMed
  65. Pan Y, et al. 2021. Br J Pharmacol. 178:4907. PubMed
  66. Pawlak EN, et al. 2018. Retrovirology. 15:6. PubMed
  67. Bengsch B et al. 2018. Immunity. 48(5):1029-1045 . PubMed
  68. Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed
  69. Moosmann C, et al. 2022. STAR Protoc. 3:101031. PubMed
  70. Cassioli C, et al. 2021. Front Cell Dev Biol. 9:673446. PubMed
  71. Sheng WY, et al. 2006. FEBS Lett. 580:6819. PubMed
  72. Naranbhai V, et al. 2022. Cell. . PubMed
  73. Celis‐Gutierrez J et al. 2019. Cell Rep. 27(11):3315-3330 . PubMed
  74. Mazer M, et al. 2019. J Immunol. 203:2088. PubMed
  75. Nomura T, et al. 2012. J Virol. 86:6481. PubMed
  76. Jones N, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01516. PubMed
  77. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  78. He Y, et al. 2021. eLife. 10:00. PubMed
  79. Ren X, et al. 2021. Lab Chip. 21:1527. PubMed
  80. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  81. Ravell JC, et al. 2020. J Clin Invest. 130:507. PubMed
  82. Bantug GR, et al. 2018. Immunity. 48:542. PubMed
  83. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  84. Martin E, et al. 2020. JCI Insight. :5. PubMed
RRID
AB_314303 (BioLegend Cat. No. 302901)
AB_314304 (BioLegend Cat. No. 302902)

Antigen Details

Structure
Ig superfamily, type I transmembrane glycoprotein, homodimer, 44 kD
Distribution

Mature T cells, thymocytes, NK cell subsets, plasma cells, EBV-positive B cells

Function
T cell costimulation
Ligand/Receptor
CD80, CD86
Cell Type
B cells, NK cells, Plasma cells, T cells, Thymocytes, Tregs
Biology Area
Costimulatory Molecules, Immunology
Molecular Family
CD Molecules
Antigen References

1. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
2. June CH, et al. 1994. Immunol. Today 15:321.
3. Linskey PS, et al. 1993. Annu. Rev. Immunol. 11:191.

Gene ID
940 View all products for this Gene ID
UniProt
View information about CD28 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD28 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-human CD28 CD28.2 FC
Biotin anti-human CD28 CD28.2 FC
FITC anti-human CD28 CD28.2 FC
PE anti-human CD28 CD28.2 FC
PE/Cyanine5 anti-human CD28 CD28.2 FC
Purified anti-human CD28 CD28.2 FC, IHC-F, Costim, FA
Alexa Fluor® 488 anti-human CD28 CD28.2 FC
Alexa Fluor® 700 anti-human CD28 CD28.2 FC
PerCP/Cyanine5.5 anti-human CD28 CD28.2 FC
Pacific Blue™ anti-human CD28 CD28.2 FC
PE/Cyanine7 anti-human CD28 CD28.2 FC
Ultra-LEAF™ Purified anti-human CD28 CD28.2 FC, IHC-F, Costim, FA
Brilliant Violet 421™ anti-human CD28 CD28.2 FC
Brilliant Violet 510™ anti-human CD28 CD28.2 FC
Purified anti-human CD28 (Maxpar® Ready) CD28.2 FC, CyTOF®
PE/Dazzle™ 594 anti-human CD28 CD28.2 FC
Brilliant Violet 785™ anti-human CD28 CD28.2 FC
Brilliant Violet 650™ anti-human CD28 CD28.2 FC
Brilliant Violet 711™ anti-human CD28 CD28.2 FC
APC/Fire™ 750 anti-human CD28 CD28.2 FC
Alexa Fluor® 647 anti-human CD28 CD28.2 FC
TotalSeq™-A0386 anti-human CD28 CD28.2 PG
TotalSeq™-B0386 anti-human CD28 CD28.2 PG
TotalSeq™-C0386 anti-human CD28 CD28.2 PG
Brilliant Violet 605™ anti-human CD28 CD28.2 FC
APC/Cyanine7 anti-human CD28 CD28.2 FC
PE anti-human CD28 CD28.2 FC
APC anti-human CD28 CD28.2 FC
Brilliant Violet 750™ anti-human CD28 CD28.2 FC
PE/Fire™ 810 anti-human CD28 CD28.2 FC
GMP PE anti-human CD28 CD28.2 FC
TotalSeq™-D0386 anti-human CD28 CD28.2 PG
Spark Violet™ 423 anti-human CD28 CD28.2 FC
Go To Top Version: 3    Revision Date: 08/25/2022

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-human CD28

  • Biotin anti-human CD28

  • FITC anti-human CD28

  • PE anti-human CD28

  • PE/Cyanine5 anti-human CD28

  • Purified anti-human CD28

  • Alexa Fluor® 488 anti-human CD28

  • Alexa Fluor® 700 anti-human CD28

  • PerCP/Cyanine5.5 anti-human CD28

  • Pacific Blue™ anti-human CD28

  • PE/Cyanine7 anti-human CD28

  • Ultra-LEAF™ Purified anti-human CD28

  • Brilliant Violet 421™ anti-human CD28

  • Brilliant Violet 510™ anti-human CD28

  • Purified anti-human CD28 (Maxpar® Ready)

  • PE/Dazzle™ 594 anti-human CD28

  • Brilliant Violet 785™ anti-human CD28

  • Brilliant Violet 650™ anti-human CD28

  • Brilliant Violet 711™ anti-human CD28

  • APC/Fire™ 750 anti-human CD28

  • Alexa Fluor® 647 anti-human CD28

  • TotalSeq™-A0386 anti-human CD28

  • TotalSeq™-B0386 anti-human CD28

  • TotalSeq™-C0386 anti-human CD28

  • Brilliant Violet 605™ anti-human CD28

  • APC/Cyanine7 anti-human CD28

  • PE anti-human CD28

  • APC anti-human CD28

  • Brilliant Violet 750™ anti-human CD28

  • PE/Fire™ 810 anti-human CD28

  • GMP PE anti-human CD28

  • TotalSeq™-D0386 anti-human CD28

  • Spark Violet™ 423 anti-human CD28

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account